BENEFICIAL EFFECTS OF LIRAGLUTIDE ON ATHEROGENIC SMALL, DENSE LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-2 DIABETES: A 2-MONTH PROSPECTIVE PILOT STUDY

被引:0
|
作者
Nikolic, D. [1 ]
Rizzo, M. [1 ]
Giglio, R. V. [1 ]
Di Bartolo, V. [1 ]
Ferlita, A. [1 ]
Zabbara, A. [1 ]
Tamburello, A. [1 ]
Giannone, V. [1 ]
Montalto, G. [1 ]
Rizvi, A. A. [2 ]
机构
[1] Univ Palermo, Biomed Dept Internal Med & Med Specialties, Palermo, Italy
[2] Univ S Carolina, Sch Med, Div Endocrinol Diabet & Metab, Columbia, SC USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:289 / 289
页数:1
相关论文
共 50 条
  • [1] INCREASED PLASMA RESISTIN CONCENTRATIONS ARE ASSOCIATED WITH ATHEROGENIC SMALL, DENSE LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-2 DIABETES
    Rizzo, M.
    Amann-Vesti, B.
    Zwimpfer, C.
    Spinas, G.
    Berneis, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 66 - 67
  • [2] Effects of liraglutide on plasma ghrelin concentrations and oxidative stress in patients with type 2 diabetes: a 2-month prospective pilot study
    Rizzo, M.
    Volti, G. Li
    Patti, A.
    Barbagallo, I.
    Di Bartolo, V.
    Giglio, V.
    Tamburello, A.
    Zabbara, A.
    Abate, N.
    Montalto, G.
    DIABETOLOGIA, 2012, 55 : S322 - S322
  • [3] The reduction in small dense low-density lipoproteins by liraglutide is independently associated with reduced carotid atherosclerosis in patients with type 2 diabetes
    Nikolic, D.
    Giglio, R. V.
    Patti, A. M.
    Castellino, G.
    Volti, G. Li
    Montalto, G.
    Rizzo, M.
    DIABETOLOGIA, 2016, 59 : S99 - S99
  • [4] BENEFICIAL EFFECTS OF LIRAGLUTIDE ON CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH TYPE-2 DIABETES: A 8-MONTH PROSPECTIVE STUDY
    Patti, A. M.
    Rizzo, M.
    Di Bartolo, V.
    Tamburello, A.
    Zabbara, A.
    Ferlita, A.
    Butera, G.
    Giannone, V.
    Rizvi, A.
    Montalto, G.
    CARDIOLOGY, 2013, 126 : 290 - 290
  • [5] Should we measure routinely oxidised and atherogenic dense low-density lipoproteins in subjects with type 2 diabetes?
    Rizzo, M.
    Berneis, K.
    Koulouris, S.
    Pastromas, S.
    Rini, G. B.
    Sakellariou, D.
    Manolis, A. S.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (12) : 1632 - 1642
  • [6] EFFECTS OF HYPOLIPIDEMIC AND HYPOGLYCAEMIC DRUGS ON ATHEROGENIC LOW-DENSITY LIPOPRO FEINTS PARTICLES IN TYPE-2 DIABETES
    Seidita, Aurelio
    Patti, Angelo Maria
    Pepe, Ilenia
    Scozzari, Francesca
    Adragna, Floriana
    Amoroso, Giorgia
    Paladino, Gabriella
    Saverino, Sergio
    Rini, GiovamBattista
    ACTA MEDICA MEDITERRANEA, 2011, 27 (02): : 63 - 71
  • [7] Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
    Dragana Nikolic
    Rosaria Vincenza Giglio
    Ali A. Rizvi
    Angelo Maria Patti
    Giuseppe Montalto
    Francesco Maranta
    Domenico Cianflone
    Anca Pantea Stoian
    Manfredi Rizzo
    Diabetes Therapy, 2021, 12 : 261 - 274
  • [8] Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect
    Nikolic, Dragana
    Giglio, Rosaria Vincenza
    Rizvi, Ali A.
    Patti, Angelo Maria
    Montalto, Giuseppe
    Maranta, Francesco
    Cianflone, Domenico
    Stoian, Anca Pantea
    Rizzo, Manfredi
    DIABETES THERAPY, 2021, 12 (01) : 261 - 274
  • [9] Ezetimibe alone and in combination lowers the concentration of small, dense low-density lipoproteins in type 2 diabetes mellitus
    Winkler, Karl
    Jacob, Stephan
    Mueller-Schewe, Tina
    Hoffmann, Michael M.
    Konrad, Thomas
    ATHEROSCLEROSIS, 2012, 220 (01) : 189 - 193
  • [10] LIPID CONSTELLATION IN LOW-DENSITY LIPOPROTEINS OF PRIMARY TYPE-2 HYPERLIPOPROTEINEMIA
    HAACKE, H
    PARWARESCH, MR
    MADER, C
    KLINISCHE WOCHENSCHRIFT, 1975, 53 (23): : 1121 - 1124